LXR Inhibitor SR9243-Loaded Immunoliposomes Modulate Lipid Metabolism and Stemness in Colorectal Cancer Cells

LXR inhibitor SR9243-loaded immunoliposomes improved the reduction of clonogenicity, stemness, and lipogenesis in CD133 + cancer stem cells in vitro, boosted reactive oxygen species generation, and induced apoptosis.